B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5077-5084

  Harp, Chelsea R Parker ^a   Archambault, Angela S ^a   Sim, Julia ^a   Ferris, Stephen T ^a   Mikesell, Robert J ^a   Koni, Pandelakis A ^b   Shimoda, Michiko ^c   Linington, Christopher ^d   Russell, John H ^a   Wu, Gregory F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELL INTERACTION; CELL SPECIFICITY; CONTROLLED STUDY; DEMYELINATION; DENDRITIC CELL; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; NEUROGENIC INFLAMMATION; PATHOLOGY;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROGENIC INFLAMMATION;

EID: 84929629444     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402236     Document Type: Article

References (53)

1. Compston, A., I. R. McDonald, J. Noseworthy, H. Lassmann, D. H. Miller, K. J. Smith, H. Wekerle, and C. Confavreux. 2006. McAlpine's Multiple Sclerosis. Churchill Livingstone, Philadelphia.
2. Frohman, E. M., M. K. Racke, and C. S. Raine. 2006. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354: 942-955.
3. Chastain, E. M., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
4. Becher, B., I. Bechmann, and M. Greter. 2006. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84: 532-543.
5. Wu, G. F., and E. Alvarez. 2011. The immunopathophysiology of multiple sclerosis. Neurol. Clin. 29: 257-278.
6. Wu, G. F., K. S. Shindler, E. J. Allenspach, T. L. Stephen, H. L. Thomas, R. J. Mikesell, A. H. Cross, and T. M. Laufer. 2011. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. J. Autoimmun. 36: 56-64.
7. Oliver, A. R., G. M. Lyon, and N. H. Ruddle. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171: 462-468.
8. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96: 2966-2974.
9. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bösl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
10. Litzenburger, T., R. Fässler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188: 169-180.
11. Bettelli, E., D. Baeten, A. Jäger, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Deviclike disease in mice. J. Clin. Invest. 116: 2393-2402.
12. Krishnamoorthy, G., H. Lassmann, H. Wekerle, and A. Holz. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392.
13. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
14. Weber, M. S., T. Prod'homme, J. C. Patarroyo, N. Molnarfi, T. Karnezis, K. Lehmann-Horn, D. M. Danilenko, J. Eastham-Anderson, A. J. Slavin, C. Linington, et al. 2010. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68: 369-383.
15. Matsushita, T., M. Horikawa, Y. Iwata, and T. F. Tedder. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185: 2240-2252.
16. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
17. Shen, P., T. Roch, V. Lampropoulou, R. A. O'Connor, U. Stervbo, E. Hilgenberg, S. Ries, V. D. Dang, Y. Jaimes, C. Daridon, et al. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507: 366-370.
18. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al; HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688.
19. Lucchinetti, C. F., W. Bruck, and H. Lassmann. 2004. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann. Neurol. 56: 308.
20. Franciotta, D., S. Columba-Cabezas, L. Andreoni, S. Ravaglia, S. Jarius, S. Romagnolo, E. Tavazzi, R. Bergamaschi, E. Zardini, F. Aloisi, and E. Marchioni. 2008. Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J. Neuroimmunol. 200: 125-128.
21. Bar-Or, A., L. Fawaz, B. Fan, P. J. Darlington, A. Rieger, C. Ghorayeb, P. A. Calabresi, E. Waubant, S. L. Hauser, J. Zhang, and C. H. Smith. 2010. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 67: 452-461.
22. Cross, A. H., J. L. Stark, J. Lauber, M. J. Ramsbottom, and J. A. Lyons. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 180: 63-70.
23. Piccio, L., R. T. Naismith, K. Trinkaus, R. S. Klein, B. J. Parks, J. A. Lyons, and A. H. Cross. 2010. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch. Neurol. 67: 707-714.
24. Molnarfi, N., U. Schulze-Topphoff, M. S. Weber, J. C. Patarroyo, T. Prod'homme, M. Varrin-Doyer, A. Shetty, C. Linington, A. J. Slavin, J. Hidalgo, et al. 2013. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J. Exp. Med. 210: 2921-2937.
25. Archambault, A. S., J. A. Carrero, L. G. Barnett, N. G. McGee, J. Sim, J. O. Wright, T. Raabe, P. Chen, H. Ding, E. J. Allenspach, et al. 2013. Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses. J. Immunol. 191: 545-550.
26. Lemos, M. P., L. Fan, D. Lo, and T. M. Laufer. 2003. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity. J. Immunol. 171: 5077-5084.
27. Shimoda, M., T. Li, J. P. Pihkala, and P. A. Koni. 2006. Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response. J. Immunol. 176: 2122-2133.
28. Racke, M. K. 2001. Experimental autoimmune encephalomyelitis (EAE). Curr. Protoc. Neurosci. Chapter 9: Unit 9.7.
29. Archambault, A. S., J. Sim, M. A. Gimenez, and J. H. Russell. 2005. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur. J. Immunol. 35: 1076-1085.
30. Shin, S., K. A. Walz, A. S. Archambault, J. Sim, B. P. Bollman, J. Koenigsknecht-Talboo, A. H. Cross, D. M. Holtzman, and G. F. Wu. 2014. Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. J. Neuroimmunol. 271: 8-17.
31. Lovitch, S. B., J. J. Walters, M. L. Gross, and E. R. Unanue. 2003. APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells. J. Immunol. 170: 4155-4160.
32. Stromnes, I. M., and J. M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810-1819.
33. Bartholomäus, I., N. Kawakami, F. Odoardi, C. Schläger, D. Miljkovic, J. W. Ellwart, W. E. Klinkert, C. Flügel-Koch, T. B. Issekutz, H. Wekerle, and A. Flügel. 2009. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462: 94-98.
34. Peters, A., L. A. Pitcher, J. M. Sullivan, M. Mitsdoerffer, S. E. Acton, B. Franz, K. Wucherpfennig, S. Turley, M. C. Carroll, R. A. Sobel, et al. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35: 986-996.
35. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
36. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigenspecific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32: 1905-1913.
37. Weber, M. S., B. Hemmer, and S. Cepok. 2011. The role of antibodies in multiple sclerosis. Biochim. Biophys. Acta 1812: 239-245.
38. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139: 4016-4021.
39. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature 314: 537-539.
40. Pape, K. A., D. M. Catron, A. A. Itano, and M. K. Jenkins. 2007. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26: 491-502.
41. Ajami, B., J. L. Bennett, C. Krieger, K. M. McNagny, and F. M. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14: 1142-1149.
42. Heppner, F. L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hövelmeyer, A. Waisman, T. Rülicke, M. Prinz, J. Priller, et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11: 146-152.
43. Marta, C. B., A. R. Oliver, R. A. Sweet, S. E. Pfeiffer, and N. H. Ruddle. 2005. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA 102: 13992-13997.
44. O'Connor, K. C., H. Appel, L. Bregoli, M. E. Call, I. Catz, J. A. Chan, N. H. Moore, K. G. Warren, S. J. Wong, D. A. Hafler, and K. W. Wucherpfennig. 2005. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 175: 1974-1982.
45. Owens, G. P., J. L. Bennett, H. Lassmann, K. C. O'Connor, A. M. Ritchie, A. Shearer, C. Lam, X. Yu, M. Birlea, C. DuPree, et al. 2009. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 65: 639-649.
46. Lambracht-Washington, D., K. C. O'Connor, E. M. Cameron, A. Jowdry, E. S. Ward, E. Frohman, M. K. Racke, and N. L. Monson. 2007. Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. 186: 164-176.
47. Varrin-Doyer, M., C. M. Spencer, U. Schulze-Topphoff, P. A. Nelson, R. M. Stroud, B. A. Cree, and S. S. Zamvil. 2012. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann. Neurol. 72: 53-64.
48. Yogev, N., F. Frommer, D. Lukas, K. Kautz-Neu, K. Karram, D. Ielo, E. von Stebut, H. C. Probst, M. van den Broek, D. Riethmacher, et al. 2012. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD- 1 receptor(+) regulatory T cells. Immunity 37: 264-275.
49. Lehmann-Horn, K., E. Schleich, D. Hertzenberg, A. Hapfelmeier, T. Kümpfel, N. von Bubnoff, R. Hohlfeld, A. Berthele, B. Hemmer, and M. S. Weber. 2011. Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders. J. Neuroinflammation 8: 146.
50. Kappos, L., H.-P. Hartung, M. S. Freedman, A. Boyko, E. W. Radü, D. D. Mikol, M. Lamarine, Y. Hyvert, U. Freudensprung, T. Plitz, and J. van Beek, ATAMS Study Group. 2014. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol. 13: 353-363.
51. Slavin, A. J., J. M. Soos, O. Stuve, J. C. Patarroyo, H. L. Weiner, A. Fontana, E. K. Bikoff, and S. S. Zamvil. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108: 1133-1139.
52. Tompkins, S. M., J. Padilla, M. C. Dal Canto, J. P. Ting, L. Van Kaer, and S. D. Miller. 2002. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168: 4173-4183.
53. Magliozzi, R., S. Columba-Cabezas, B. Serafini, and F. Aloisi. 2004. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148: 11-23.